Ben R. Taylor

Insider Reports History

Location
Salt Lake City, UT
Signature
/s/ Kyle Nelson, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ben R. Taylor:

Company Role Class Num Shares Value Price $ Report Date Ownership
RECURSION PHARMACEUTICALS, INC. Chief Financial Officer Class A Common Stock 782,933 $3,390,099 $4.33 15 Dec 2025 Direct
RECURSION PHARMACEUTICALS, INC. Chief Financial Officer Stock Option (Right to Buy) 289,837 16 Jun 2025 Direct

Insider Reports Filed by Ben R. Taylor

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RXRX RECURSION PHARMACEUTICALS, INC. 29 Dec 2025 1 -$89,381 4 Chief Financial Officer 30 Dec 2025, 19:35
RXRX RECURSION PHARMACEUTICALS, INC. 15 Dec 2025 1 -$30,557 4 Chief Financial Officer 17 Dec 2025, 18:34
RXRX RECURSION PHARMACEUTICALS, INC. 25 Nov 2025 1 -$9,152 4 Chief Financial Officer 26 Nov 2025, 17:14
RXRX RECURSION PHARMACEUTICALS, INC. 17 Nov 2025 1 -$49,299 4 Chief Financial Officer 19 Nov 2025, 19:37
RXRX RECURSION PHARMACEUTICALS, INC. 15 Sep 2025 1 -$34,085 4 Chief Financial Officer 17 Sep 2025, 16:45
RXRX RECURSION PHARMACEUTICALS, INC. 15 Aug 2025 1 -$67,161 4 Chief Financial Officer 19 Aug 2025, 18:22
RXRX RECURSION PHARMACEUTICALS, INC. 16 Jun 2025 1 -$34,720 4 Chief Financial Officer 18 Jun 2025, 16:32
RXRX RECURSION PHARMACEUTICALS, INC. 15 May 2025 1 -$50,609 4 Chief Financial Officer 19 May 2025, 16:44
RXRX RECURSION PHARMACEUTICALS, INC. 01 Apr 2025 1 -$135,379 4 Chief Financial Officer 03 Apr 2025, 16:38
RXRX RECURSION PHARMACEUTICALS, INC. 17 Mar 2025 1 -$48,270 4 Chief Financial Officer 19 Mar 2025, 16:27
RXRX RECURSION PHARMACEUTICALS, INC. 18 Feb 2025 1 -$115,753 4 Chief Financial Officer 20 Feb 2025, 16:42
RXRX RECURSION PHARMACEUTICALS, INC. 03 Feb 2025 4 -$47,444 4 Chief Financial Officer 05 Feb 2025, 16:50
RXRX RECURSION PHARMACEUTICALS, INC. 19 Dec 2024 2 $0 4 Chief Financial Officer 20 Dec 2024, 16:16
RXRX RECURSION PHARMACEUTICALS, INC. 16 Dec 2024 2 -$143,681 4 Chief Financial Officer 18 Dec 2024, 18:49
RXRX RECURSION PHARMACEUTICALS, INC. 20 Nov 2024 0 $0 3 Chief Financial Officer 02 Dec 2024, 19:02